<DOC>
	<DOCNO>NCT01451619</DOCNO>
	<brief_summary>This study assess effect MK-0524 relative placebo , sign symptom rosacea determine safety tolerability profile MK-0524 participant rosacea .</brief_summary>
	<brief_title>A Study Laropiprant ( MK-0524 ) Participants With Moderate Severe Erythematotelangiectatic Rosacea ( MK-0524-155 )</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>Moderate severe erythematotelangiectatic rosacea moderate severe erythema facial lesion Generally healthy exclude rosacea Presence telangiectasia Five le facial inflammatory lesion Able restrict diet order avoid foods/drinks ( include alcohol ) know exacerbate signs/symptoms rosacea Females childbearing potential must negative serum pregnancy test agree use one form contraception Diagnosis skin disorder , include psoriasis , acne vulgaris , perioral dermatitis atopic dermatitis would interfere clinical evaluation rosacea Using unable discontinue use phosphodiesterase ( PDE ) 4 inhibitor , theophylline , niacin great 500 mg/day Known suspect excessive alcohol intake Sensitivity tetracyclines Ocular rosacea and/or blepharitis/meibomianitis Pregnant breastfeeding Perimenopausal symptom cause flushing may affect rosacea Initiated hormonal method birth contraception within 4 month baseline , discontinues use course study , change hormonal method within 4 month Active mycobacterial infection specie within 3 year History mycobacterium tuberculosis infection History recurrent bacterial infection Congenital acquire immunodeficiency common variable immunodeficiency ( CVID ) , Hepatitis B surface antigen positive Hepatitis B core antibody positive Human immunodeficiency virus ( HIV ) infection Positive hepatitis C antibodies Malignancy history malignancy great 3 year prior Will continue use follow treatment study : Systemic retinoids , therapeutic vitamin A supplement great 10,000 units/day , systemic steroid , systemic antibiotic know impact severity facial rosacea , systemic treatment acne , topical steroid , topical retinoids , topical acne treatment include prescription overthecounter ( OTC ) preparation , topical antiinflammatory agent , topical antibiotic , topical imidazole antimycotic , cryodestruction chemodestruction , dermabrasion , photodynamic therapy , acne surgery , intralesional steroid , Xray therapy , pulsedye laser , intense pulse light , astringent , abrasive , benzoyl peroxide product , sulfur contain wash , eye wash , Beta blocker , vasodilator , vasoconstrictor and/or chronic use ( &gt; 14 day ) topical systemic antiinflammatory agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>